Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$346,589,048
+$28,095,463 QoQ
Shares Held
1,364,685
+4.7% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#131
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $2,100,933,315 across 14 Drug Manufacturers - General names. JNJ ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
694,293 | $832,755,921 | |
| 2 | AZN |
Astrazeneca PLC
|
2,332,566 | $442,301,164 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
1,364,685 | $346,589,048 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,843,591 | $236,901,443 | |
| 5 | ABBV |
AbbVie Inc.
|
254,499 | $64,042,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,063,855 | $61,299,324 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
284,948 | $36,000,330 | |
| 8 | NVO |
Novo Nordisk A S
|
657,641 | $31,527,309 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,589,048 | 1,364,685 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $318,493,585 | 1,302,952 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $187,195,793 | 904,546 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $161,945,826 | 873,400 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $118,879,367 | 778,261 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $114,180,507 | 688,498 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $92,251,650 | 637,890 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $703,852,994 | 4,343,163 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $741,227,783 | 5,071,345 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $930,101,040 | 5,879,645 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $930,260,832 | 5,935,057 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,136,353,399 | 7,296,009 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,756,740,062 | 10,613,461 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,419,723,740 | 9,159,508 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,583,500,844 | 8,964,058 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,529,828,008 | 9,364,765 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,685,221,537 | 9,493,671 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,737,976,217 | 9,806,332 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,710,514,558 | 9,998,916 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,664,888,157 | 10,308,905 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,715,764,792 | 10,414,986 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,748,182,073 | 10,636,946 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,586,058,955 | 10,077,894 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,509,499,083 | 10,139,032 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,398,082,144 | 9,941,564 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,165,831,064 | 8,890,651 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||